Merck recalls a lot of Vytorin; India's Kilitch says it will partner on a drug plant in Ethiopia;

> Merck ($MRK) is voluntarily recalling one lot of its combo statin Vytorin after a larger-dose tablet was found in a bottle of 10 mg/20mg tablets. Notice

> The FDA has awarded a $4.9 million grant to a Rutgers University-led research consortium to study continuous manufacturing. Report

> Fertin India Private is opening the country's first medicated chewing gum manufacturing plant to make a Nicotine Replacement Therapy. Report

> Indian drugmaker Kilitch Drugs in a filing with the Bombay Stock Exchange said it has formed a joint venture an Ethiopian partner to establish a manufacturing plant in the African country. Report

Suggested Articles

Gilead Sciences will add 140 jobs to its Irish operations as part of an expansion to its Dublin distribution center, the Irish Times reported.

GSK's Shingrix supply has recovered after COVID-19 prompted a slowdown in vaccinations.

Moderna will delegate fill-finish duties for "hundreds of millions" of doses of its COVID-19 vaccine to Spain's Laboratorios Farmacéuticos Rovi.